Both Wegovy (semaglutide 7.2mg) and Mounjaro (tirzepatide 15mg) are highly effective for long-term weight loss, but they work slightly differently and may affect people differently.
In 72 weeks, people taking Wegovy 7.2mg in a clinical study lost an average of 20.7% of their body weight when taken as directed. This means that someone who weighs 100kg may lose 20.7kg on average in 72 weeks (1 year, 5 months).*
In 72 weeks, people taking Mounjaro 15mg in a clinical study lost an average of 22.5% of their body weight when taken as directed. This means that someone who weighs 100kg may lose 22.5kg on average in 72 weeks (1 year, 5 months).**
These are examples only. It is not a prediction of individual results.
Both can be excellent options. The right choice comes down to your health needs, goals, lifestyle and how your body responds to treatment. Our medical team will help you find what works best for you.
*STEP UP, 72-week study of adults with obesity using Wegovy (semaglutide 7.2mg). Individual results vary.
**SURMOUNT-1, 72-week study of adults with obesity using Mounjaro (tirzepatide 15mg). Individual results vary.